Appendix B
Acronyms

AIDS acquired immunodeficiency syndrome

ANRS Agence Nationale de Recherche sur le Sida (France)

ANVISA Brazilian National Health Vigilance Agency

ART antiretroviral therapy

AVAC AIDS Vaccine Advocacy Coalition

CAPRISA Centre for the AIDS Program of Research in South Africa

CDC Centers for Disease Control and Prevention (U.S.)

CMED Medicines Market Regulation Chamber

DMC Data Monitoring Committee

DSMB Data Safety Monitoring Board

EIA enzyme immunoassay

ELISA Enzyme-Linked ImmunoSorbent Assay

EMEA European Agency for the Evaluation of Medicinal Products

FDA Food and Drug Administration (U.S.)

FHI Family Health International

HIV human immunodeficiency virus

HPTN HIV Prevention Trials Network

HSV herpes simplex virus

HVTN HIV Vaccine Trials Network

IAVI International AIDS Vaccine Initiative

IND Investigational New Drug application (to FDA, U.S.)

IOM Institute of Medicine (U.S.)

IPM International Partnership for Microbicides

ITT intent-to-treat analysis

MCC Medicines Control Council (South Africa)



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 234
Appendix B Acronyms AIDS acquired immunodeficiency syndrome ANRS Agence Nationale de Recherche sur le Sida (France) ANVISA Brazilian National Health Vigilance Agency ART antiretroviral therapy AVAC AIDS Vaccine Advocacy Coalition CAPRISA Centre for the AIDS Program of Research in South Africa CDC Centers for Disease Control and Prevention (U.S.) CMED Medicines Market Regulation Chamber DMC Data Monitoring Committee DSMB Data Safety Monitoring Board EIA enzyme immunoassay ELISA Enzyme-Linked ImmunoSorbent Assay EMEA European Agency for the Evaluation of Medicinal Products FDA Food and Drug Administration (U.S.) FHI Family Health International HIV human immunodeficiency virus HPTN HIV Prevention Trials Network HSV herpes simplex virus HVTN HIV Vaccine Trials Network IAVI International AIDS Vaccine Initiative IND Investigational New Drug application (to FDA, U.S.) IOM Institute of Medicine (U.S.) IPM International Partnership for Microbicides ITT intent-to-treat analysis MCC Medicines Control Council (South Africa) 

OCR for page 234
 APPENDIX B MDP Microbicides Development Programme MRC Medical Research Council MTN Microbicide Trial Network NIAID National Institute of Allergy and Infectious Diseases (U.S.) NIH National Institutes of Health (U.S.) PEP post-exposure prophylaxis PI principal investigator PrEP pre-exposure prophylaxis STD sexually transmitted disease STI sexually transmitted infection TDF tenofovir disoproxil fumarate UNAIDS The Joint United Nations Programme on HIV/AIDS USAID U.S. Agency for International Development WHO World Health Organization